Renal Biomarkers: Technologies and Global Markets
Report Scope:
This report incorporates an in-depth analysis of the renal biomarker market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the CAGR for renal biomarkers.
The scope of the report extends only to renal biomarker consumables and not devices used to study renal biomarkers. All types of renal biomarkers have been considered in research, clinical trials and for diagnostic purposes.
This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW) region. For market estimates, data is provided for 2021 as the base year, 2022 and forecast through year-end 2027.
Report Includes:
41 data tables and 24 additional tables
A detailed overview and up-to-date analysis of the global markets for renal biomarkers
Analyses of the global market trends, with market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Estimation of the actual market size and revenue forecast for renal biomarkers market, and corresponding market share analysis by assay type, application, end user, and region
Updated information on market drivers and opportunities for renal biomarkers, key shifts, regulations and industry specific challenges, and other demographic factors that will shape the market demand over the coming years (2022-2027)
Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages
Review of recent industry structure for biomarkers, R&D activities, and analysis of the competitive landscape based on recent developments and segmental revenues
Patent activity and review of patent grants for biomarkers and related technologies
Descriptive company profiles of the market leading players, including BioMerieux, Gentian Diagnostic, Proteomics International, Thermo Fisher Scientific, SphingoTec, and BioPorto
Companies Mentioned<\b>
ABBOTT LABORATORIES
BECKMAN COULTER INC.
Bio-Rad
BIOMERIEUX
Bioporto A/s
ENZO BIOCHEM INC.
Gentian Diagnostic Ab
HYTEST LTD.
Nephrosant
Nexelis
Proteomics International Laboratories Ltd.
RANDOX LABORATORIES LTD.
ROCHE (F. HOFFMANN-LA ROCHE AG)
Sphingotec
THERMO FISHER SCIENTIFIC
- Chapter 1 Introduction
- 1.1 Study Goals and Objectives
- 1.2 Reasons for Doing this Study
- 1.3 What's New in this Report
- 1.4 Scope of Report
- 1.5 Information Sources
- 1.6 Methodology
- 1.7 Geographic Breakdown
- 1.8 Analyst's Credentials
- 1.9 BCC Custom Research
- 1.10 Related BCC Research Reports
- Chapter 2 Summary and Highlights
- Chapter 3 Market Overview
- 3.1 Introduction
- 3.1.1 Kidneys
- 3.1.2 Renal Biomarkers
- 3.1.3 Definition
- 3.2 Market Dynamics
- 3.2.1 Drivers
- 3.2.2 Restraints
- 3.2.3 Opportunities
- 3.3 Regulatory Process for Biomarkers
- 3.3.1 European Medicines Agency
- 3.3.2 Biomarkers Qualified by the FDA
- Chapter 4 Impact of COVID-19 Pandemic
- 4.1 Impact of COVID-19 on Renal Biomarker Market
- 4.1.1 Increased Incidence of AKI
- 4.1.2 Other Diseases
- 4.2 Chronic Dialysis Patients
- 4.2.1 Kidney Transplant Recipients
- Chapter 5 Global Renal Biomarker Market by Type
- 5.1 Overview
- 5.2 Filtered Renal Biomarkers (Impaired Tubular Reabsorption)
- 5.2.1 Albumin
- 5.2.2 Cystatin C
- 5.2.3 Beta-2 Microglobulin
- 5.3 Upregulated Biomarkers
- 5.3.1 KIM-1 Kidney Injury Molecule
- 5.3.2 Neutrophil Gelatinase Associated Lipocalin
- 5.3.3 Clusterin
- 5.3.4 Interleukin-18
- 5.3.5 Netrin-1
- 5.4 Preformed
- 5.4.1 Alkaline Phosphatase
- 5.4.2 Gamma-Glutamyl Transpeptidase
- 5.4.3 Glutathione S-Transferase
- 5.4.4 N-acetyl-β-D Glucosaminidase
- 5.4.5 Liver-Type Fatty Acid-Binding Protein
- 5.4.6 Tissue Inhibitor of Metalloprotease-2 and Insulin-Like Growth Factor-binding Protein 7
- 5.5 Other Biomarkers
- 5.5.1 Blood Urea Nitrogen
- 5.5.2 Serum Creatinine
- 5.5.3 Downregulated
- Chapter 6 Global Market for Renal Biomarkers by Region
- 6.1 North America
- 6.1.1 United States
- 6.1.2 Canada
- 6.2 Europe
- 6.2.1 Germany
- 6.2.2 Italy
- 6.2.3 France
- 6.2.4 Spain
- 6.2.5 United Kingdom
- 6.2.6 Rest of Europe
- 6.3 Asia-Pacific
- 6.3.1 Australia
- 6.3.2 Japan
- 6.3.3 China
- 6.3.4 Rest of Asia
- 6.4 Rest of the World
- Chapter 7 Renal Biomarker Market by End User
- 7.1 Hospitals
- 7.2 Research Centers
- 7.3 Other End Users
- Chapter 8 Renal Biomarker Market by Technique
- 8.1 Overview
- 8.2 Enzyme Linked Immunosorbent Assay
- 8.3 Particle-Enhanced Turbidimetric Immunoassays
- 8.4 Colorimetric Assays
- 8.5 Chemiluminescent Enzyme Immunoassays
- 8.6 Other Detection Methods
- Chapter 9 Competitive Landscape
- Chapter 10 Company Profiles
- ABBOTT LABORATORIES
- BECKMAN COULTER INC.
- BIOMERIEUX
- BIOPORTO A/S
- BIO-RAD
- ENZO BIOCHEM INC.
- GENTIAN DIAGNOSTIC AB
- HYTEST LTD.
- NEPHROSANT
- Nexelis
- PROTEOMICS INTERNATIONAL LABORATORIES LTD.
- RANDOX LABORATORIES LTD.
- ROCHE (F. HOFFMANN-LA ROCHE AG)
- SPHINGOTEC
- THERMO FISHER SCIENTIFIC
- Chapter 11 Patent Review
- Chapter 12 Clinical Trial Analysis
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook